140 related articles for article (PubMed ID: 20056905)
1. Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model.
Henneke I; Greschus S; Savai R; Korfei M; Markart P; Mahavadi P; Schermuly RT; Wygrecka M; Stürzebecher J; Seeger W; Günther A; Ruppert C
Am J Respir Crit Care Med; 2010 Mar; 181(6):611-9. PubMed ID: 20056905
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of vitamin C in combination with vitamin K3 on tumor growth and metastasis of Lewis lung carcinoma xenografted in C57BL/6 mice.
Chen MF; Yang CM; Su CM; Liao JW; Hu ML
Nutr Cancer; 2011; 63(7):1036-43. PubMed ID: 21888506
[TBL] [Abstract][Full Text] [Related]
3. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model.
Kobayashi H; Fukuda Y; Yoshida R; Kanada Y; Nishiyama S; Suzuki M; Kanayama N; Terao T
Int J Cancer; 2004 Nov; 112(3):519-24. PubMed ID: 15382080
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
5. Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents.
Schweinitz A; Steinmetzer T; Banke IJ; Arlt MJ; Stürzebecher A; Schuster O; Geissler A; Giersiefen H; Zeslawska E; Jacob U; Krüger A; Stürzebecher J
J Biol Chem; 2004 Aug; 279(32):33613-22. PubMed ID: 15150279
[TBL] [Abstract][Full Text] [Related]
6. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
[TBL] [Abstract][Full Text] [Related]
7. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
8. Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice.
Yan L; DeMars LC
Int J Cancer; 2012 Sep; 131(6):1260-6. PubMed ID: 22095442
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
10. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Fujie M; Shinohara H; Moniwa N; Terao T
Int J Cancer; 1994 Jun; 57(5):727-33. PubMed ID: 8194882
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
13. Aspirin reduces lung cancer metastasis to regional lymph nodes.
Ogawa F; Amano H; Ito Y; Matsui Y; Hosono K; Kitasato H; Satoh Y; Majima M
Biomed Pharmacother; 2014 Feb; 68(1):79-86. PubMed ID: 24331369
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells.
Chu SC; Yang SF; Liu SJ; Kuo WH; Chang YZ; Hsieh YS
Food Chem Toxicol; 2007 Jul; 45(7):1194-201. PubMed ID: 17303298
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N
Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice.
Jankun J; Keck RW; Skrzypczak-Jankun E; Swiercz R
Cancer Res; 1997 Feb; 57(4):559-63. PubMed ID: 9044824
[TBL] [Abstract][Full Text] [Related]
17. The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostate tumor in SCID mice.
Billström A; Hartley-Asp B; Lecander I; Batra S; Astedt B
Int J Cancer; 1995 May; 61(4):542-7. PubMed ID: 7759160
[TBL] [Abstract][Full Text] [Related]
18. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
[TBL] [Abstract][Full Text] [Related]
19. Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
Tang SJ; Ho MY; Cho HC; Lin YC; Sun GH; Chi KH; Wang YS; Jhou RS; Yang W; Sun KH
Int J Cancer; 2008 Dec; 123(12):2840-8. PubMed ID: 18814280
[TBL] [Abstract][Full Text] [Related]
20. Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo.
Yang SF; Chu SC; Liu SJ; Chen YC; Chang YZ; Hsieh YS
J Ethnopharmacol; 2007 Apr; 110(3):483-9. PubMed ID: 17113737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
